Related Experiment Videos
Distinct functional properties of IkappaB alpha and IkappaB beta
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York 10032, USA.
Insights
IkappaB alpha is a more potent inhibitor of NF-kappaB than IkappaB beta, primarily by blocking DNA binding and removing NF-kappaB from transcription complexes. Both proteins function in the nucleus, but IkappaB beta
Area of Science:
- Molecular Biology
- Cell Biology
- Gene Regulation
Background:
- Nuclear Factor-kappaB (NF-kappaB) is a crucial transcription factor.
- Its activity is primarily regulated by Inhibitor of kappaB (IkappaB) proteins, specifically IkappaB alpha and IkappaB beta.
- These proteins sequester NF-kappaB in the cytoplasm and inhibit its DNA-binding activity.
Purpose of the Study:
- To compare the distinct mechanisms by which IkappaB alpha and IkappaB beta inhibit NF-kappaB-dependent transcriptional activation.
- To elucidate the roles of IkappaB proteins in both cytoplasmic and nuclear compartments.
- To investigate factors modulating IkappaB beta's inhibitory function.
Main Methods:
- In vitro and in vivo experiments were conducted to assess NF-kappaB inhibition.
- DNA-binding assays were used to evaluate the interaction between NF-kappaB and IkappaB proteins.
- In vitro transcription assays were performed to analyze the effect on preinitiation complexes.
- Phosphorylation status and interactions with High-Mobility Group I (HMG I) were examined.
Main Results:
- IkappaB alpha demonstrated stronger inhibition of NF-kappaB than IkappaB beta, correlating with superior DNA-binding inhibition.
- IkappaB alpha effectively removed NF-kappaB from preinitiation complexes, a function not observed with IkappaB beta.
- Both IkappaB alpha and IkappaB beta were found to inhibit NF-kappaB activity within the nucleus.
- IkappaB beta's inhibitory function was modulated by C-terminal PEST sequence phosphorylation and HMG I interaction, unlike IkappaB alpha.
Conclusions:
- IkappaB alpha acts as a postinduction repressor of NF-kappaB, independent of HMG I.
- IkappaB beta's function is preferentially associated with promoters regulated by NF-kappaB/HMG I complexes.
- Differential mechanisms employed by IkappaB alpha and IkappaB beta highlight the complexity of NF-kappaB regulation.
Abstract:
The biological activity of the transcription factor NF-kappaB is controlled mainly by the IkappaB alpha and IkappaB beta proteins, which restrict NF-kappaB to the cytoplasm and inhibit its DNA binding activity. Here, we carried out experiments to determine and compare the mechanisms by which IkappaB alpha and IkappaB beta inhibit NF-kappaB-dependent transcriptional activation. First, we found that in vivo IkappaB alpha is a stronger inhibitor of NF-kappaB than is IkappaB beta. This difference is directly correlated with their abilities to inhibit NF-kappaB binding to DNA in vitro and in vivo. Moreover, IkappaB alpha, but not IkappaB beta, can remove NF-kappaB from functional preinitiation complexes in in vitro transcription experiments. Second, we showed that both IkappaBs function in vivo not only in the cytoplasm but also in the nucleus, where they inhibit NF-kappaB binding to DNA. Third, the inhibitory activity of IkappaB beta, but not that of IkappaB alpha, is facilitated by phosphorylation of the C-terminal PEST sequence by casein kinase II and/or by the interaction of NF-kappaB with high-mobility group protein I (HMG I) on selected promoters. The unphosphorylated form of IkappaB beta forms stable ternary complexes with NF-kappaB on the DNA either in vitro or in vivo. These experiments suggest that IkappaB alpha works as a postinduction repressor of NF-kappaB independently of HMG I, whereas IkappaB beta functions preferentially in promoters regulated by the NF-kappaB/HMG I complexes.